GERN

In the past six months (April-October 2026), Geron's stock performance was influenced by strong Q2 2026 financial results, reporting RYTELO net product revenue of $57.5 million, an 11% sequential and 17% year-over-year increase, with a 5% growth in demand and an 8% increase in ordering accounts. This led to a 21.6% stock jump in early August 2026, and the company maintained its full-year 2026 revenue guidance of $220 million to $240 million. Geron participated in several investor conferences and reported inducement grants. Despite positive revenue, the company continues to operate with a net loss, and its cash balance modestly reduced. Analysts have a consensus 'Hold' rating with an average price target of $4.00.